News and Media Filter All News Article Press Release Webcast Page: 1 of 4 March 22, 2023 Press Release Remix Therapeutics Appoints Robert Gagnon as Chief Financial Officer January 5, 2023 Press Release Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer December 8, 2022 Press Release Remix Therapeutics to Present at 5th Annual RNA-Targeted Drug Discovery Summit May 31, 2022 Press Release Remix Therapeutics to Present at Jefferies Healthcare Conference May 31, 2022 Webcast Jefferies Healthcare Conference 2022: Remix Therapeutics Corporate Overview Media Contact Lissette Steele Verge Scientific Communications 202.930.4762 lsteele@vergescientific.com Media Contact Lissette Steele Verge Scientific Communications 202.930.4762 lsteele@vergescientific.com
